I'm disregarding ALL of Alpha's posts/articles/opinions from now on, call them what you will, as it's very obvious that behind this seemingly due diligence are trading agendas of the principals involved.
To see repeated unabashed earlier proclamations praising and recommending stem cell stocks like ACTC and NBS, to name just a few and then nefariously talk them down for apparent ulterior trading objectives and then with such weak premises about the stem cell industry and it's promise, is unbelievable, imo.
